These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28942916)

  • 21. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
    Salmon-Ceron D; Lewden C; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
    J Hepatol; 2005 Jun; 42(6):799-805. PubMed ID: 15973779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
    Hansen AB; Lohse N; Gerstoft J; Kronborg G; Laursen A; Pedersen C; Sørensen HT; Obel N
    PLoS One; 2007 Aug; 2(8):e738. PubMed ID: 17710138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.
    Yeung MW; Young J; Moodie E; Rollet-Kurhajec KC; Schwartzman K; Greenaway C; Cooper C; Cox J; Gill J; Hull M; Walmsley S; Klein MB
    HIV Clin Trials; 2015; 16(3):100-10. PubMed ID: 25972048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research on the causes of death associated with combined effects of HBV and HCV infection in patients with acquired immunodeficiency syndrome].
    Guo PL; Cai WP; Chen XJ; He HL; Hu FY; Tang XP; Li LH
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):495-498. PubMed ID: 30317770
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
    Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
    J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Kovari H; Rauch A; Kouyos R; Rougemont M; Cavassini M; Schmid P; Stöckle M; Bernasconi E; Weber R; Ledergerber B;
    Clin Infect Dis; 2017 Feb; 64(4):490-497. PubMed ID: 28172403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China.
    Chen X; Liu X; Tang R; Ye R; Yang Y; Yao S; Wang J; Ding Y; Duan S; He N
    Biosci Trends; 2019 Mar; 13(1):32-39. PubMed ID: 30726798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
    Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
    Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
    Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP;
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):786-791. PubMed ID: 28418984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
    PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women.
    Löf M; Sandin S; Yin L; Adami HO; Weiderpass E
    Eur J Epidemiol; 2015 Sep; 30(9):1027-34. PubMed ID: 26076920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race but not Hepatitis C co-infection affects survival of HIV
    Sawinski D; Forde KA; Locke JE; Cohen JB; Weldon J; Shults J; Reese PP
    Kidney Int; 2018 Mar; 93(3):706-715. PubMed ID: 29107361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of coffee consumption with mortality.
    Lopez-Garcia E; van Dam RM; Li TY; Rodriguez-Artalejo F; Hu FB
    Ann Intern Med; 2008 Jun; 148(12):904-14. PubMed ID: 18559841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).
    Barré T; Mercié P; Marcellin F; Esterle L; Duvivier C; Teicher E; Bureau M; Chas J; Salmon-Céron D; Sogni P; Carrieri MP; Wittkop L; Protopopescu C;
    AIDS Behav; 2021 Dec; 25(12):4141-4153. PubMed ID: 33903998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
    Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F;
    Clin Infect Dis; 2015 Jul; 61(1):40-8. PubMed ID: 25778750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
    Sarkar M; Bacchetti P; French AL; Tien P; Glesby MJ; Nowicki M; Plankey M; Gange S; Sharp G; Minkoff H; Peters MG;
    Hepatology; 2012 Nov; 56(5):1699-705. PubMed ID: 22618868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.